PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.270
-0.035 (-2.68%)
Oct 23, 2026, 4:00 PM EDT - Market closed
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $95.9 million as of October 23, 2026. It is the 25,394th most valuable company in the world and the 4,116th biggest in the United States. Its market cap has increased by 17.51% in one year.
Market Cap
95.90M
Enterprise Value
16.69M
1-Year Change
17.51%
Global Rank
Country Rank
#4,116 United States
Category
ChartMarket Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $95.90M, a decrease of -94.05%. That is a compound annual growth rate of -37.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 95.90M | 44.18% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 102.12M |
| Tenax Therapeutics | 100.82M |
| Milestone Pharmaceuticals | 99.02M |
| Immunic | 98.51M |
| Vivani Medical | 98.32M |
| Coya Therapeutics | 97.12M |
| Polaryx Therapeutics | 96.70M |
| Anixa Biosciences | 96.64M |